Company Profile — Digital Health · Jakarta, Indonesia

Halodoc
Hello, Doctor.

The Indonesian app that put a doctor, a pharmacy, a lab and an insurer into a single login - and reached 20 million people a month doing it.

20M+Monthly users

20K+Doctors

~$258MRaised

2016Founded

HALODOC — Jakarta, Indonesia. The wordmark of a health-tech platform that began with a simple chat with a doctor and grew into a nationwide super app. Photographed: the official brand logotype.

The Dispatch

A hospital that fits in your pocket

Indonesia is a country of roughly 270 million people spread across some 17,000 islands, served by far fewer doctors per capita than most of its neighbors. For millions, seeing a physician has long meant travel, traffic and a wait. Halodoc was built around a plain observation: if the patient cannot easily get to the doctor, bring the doctor to the phone.

Founded in Jakarta in 2016 by Jonathan Sudharta and Doddy Lukito, Halodoc is a digital health platform that bundles four things people usually chase separately - a doctor consultation, medicine, a lab test and insurance - into one mobile app. A user can chat, call or video a licensed doctor, receive an e-prescription, order the medicine, and have it delivered, often within an hour. They can book a lab test to be done at home, schedule a hospital appointment, and link insurance for cashless visits.

"Simplify access to healthcare by connecting patients with doctors, pharmacies, labs and insurance in one app." - Halodoc's stated mission

That combination is the point. Plenty of apps do telemedicine. Fewer own the full loop from symptom to delivered treatment. Halodoc's answer to Indonesia's access problem is less a clever algorithm than a stitched-together network - 20,000+ doctors, 4,000+ pharmacies, 1,400+ hospitals - operating behind a single, ordinary-looking icon on a phone.

By The Numbers

The scale of the network

0Million monthly users

0Thousand+ doctors

0Partner pharmacies

0Partner hospitals

The Customers

Who's on the other end

Halodoc's core users are everyday Indonesian consumers - a parent checking a child's fever at midnight, an office worker who can't afford a half-day off for a clinic queue, someone in a smaller town far from a specialist. On the supply side, its customers include the doctors, pharmacies, hospitals and insurers who plug into the platform to reach those patients.

It's a two-sided health marketplace: consumers get convenience; providers get demand and distribution. The app runs on iOS and Android and counts more than 20 million monthly active users.

The Problem

Access, distance, waiting

The frictions Halodoc attacks are unglamorous: the distance to a clinic, the hours lost in traffic and waiting rooms, the pharmacy trip after the appointment, the confusion of paying and claiming insurance. Each is a small barrier. Stacked together, they keep people from care.

By collapsing consultation, prescription, delivery, testing and payment into one flow, Halodoc removes the hand-offs where people usually give up. When COVID-19 arrived, that same design turned a convenience into a lifeline.

Products & Services

What you can actually do with it

SINCE 2016

Doctor Consultation

Chat, voice or video with 20,000+ licensed doctors, with digital e-prescriptions.

SINCE 2016

Online Pharmacy

Order medicine from 4,000+ pharmacies, delivered - often within about an hour.

SINCE 2018

Home Lab Tests

Book diagnostics done at home; results delivered digitally inside the app.

SINCE 2019

Hospital Appointments

Book and manage visits across 1,400+ hospitals, with cashless options.

SINCE 2020

Insurance Integration

Buy and connect third-party health insurance to consultations and visits.

SINCE 2024

AI Preventive Health

A proactive wellness dashboard nudging users toward prevention and chronic care.

Business Model

How the money moves

Halodoc sits between patients and providers and takes a cut of the transactions that flow through. Revenue comes from margins on medicine and e-pharmacy sales, consultation and lab fees, and partnership arrangements with hospitals and insurers. More recently it has leaned into product bundling and chronic-care subscriptions to deepen each relationship.

A third-party estimate pegs annual revenue near US$45M, though the company has not published official figures, and it has signaled 2025 profitability targets.

The Edge

Why it's hard to copy

Competitors like Alodokter, Good Doctor and SehatQ offer overlapping features. Halodoc's differentiator is less the app and more the logistics behind it: an early, tight partnership with ride-hailing giant Gojek folded on-demand medicine delivery into the experience, giving Halodoc same-hour fulfilment that's expensive to replicate.

Owning the full loop - and the trust that comes from licensed doctors, real prescriptions and cashless hospital links - is the moat. In healthcare, credibility scales slowly and copies poorly.

Distribution beats invention: Halodoc's edge isn't a clever algorithm - it's the pharmacies, hospitals and delivery network stitched into one login.

Funding

Roughly $258M, six rounds

Series A2016

~$13M

Series B2019

$65M

Series C2021

$80M

Series D2023

$100M

Backers span venture and strategic heavyweights: Gojek and Clermont Group early on; UOB Venture Management, Singtel Innov8 and Korea Investment Partners at Series B; Temasek, Novo Holdings and the Bill & Melinda Gates Foundation at Series C; and Indonesian conglomerate Astra leading the $100M Series D in 2023, bringing Astra's total investment to around $135M.

Timeline

From chat app to super app

2016

Founded in Jakarta

Jonathan Sudharta and Doddy Lukito launch Halodoc, with a ~$13M Series A backed by Gojek and others.

2017

Gojek integrates Go-Med

On-demand medicine delivery is embedded into the Halodoc experience.

2019

$65M Series B

UOB Venture Management leads as Halodoc expands services and coverage.

2020

Telemedicine surges in COVID-19

Halodoc becomes a key channel for remote consultations and medicine delivery.

2021

$80M Series C

Astra and Temasek back the round as the hospital, lab and insurance network scales.

2023

$100M Astra-led Series D

Openspace and Novo Holdings join; total funding reaches ~$258M.

2024

Toward proactive wellness

Halodoc launches an AI-driven preventive health dashboard, moving beyond reactive telehealth.

Where It Fits

A backbone for Indonesian digital health

Southeast Asia's health-tech market has cycled through hype and retrenchment. Halodoc's position has stayed consistent: a broad, consumer-facing platform aiming to be the default front door to healthcare in Indonesia, the region's largest market. Astra's $100M bet in 2023 - old-economy conglomerate backing new-economy health - reads as a signal that digital health is graduating from experiment toward infrastructure.

Its expertise is operational: running a real-time marketplace across doctors, pharmacies, labs, hospitals and insurers, and moving physical medicine reliably across a sprawling archipelago. That is a logistics problem as much as a medical one, and it is the part rivals find hardest to match. The next chapter leans on that reach - a deeper rural push via Astra's distribution and midwife platforms, targeting the health workers who manage an estimated 60% of Indonesia's births.

The company has also begun to shift its center of gravity. For most of its history Halodoc was reactive: you felt unwell, you opened the app. The newer ambition is preventive - an AI-driven dashboard that surfaces health signals and nudges users toward check-ups, chronic-care routines and healthier habits before a problem becomes urgent. Reported early figures point to meaningfully higher retention from that proactive layer. It is a quieter kind of product than a flashy consultation feature, but in public-health terms the best appointment is often the one a person never needs to book. If it works at scale, it moves Halodoc from a place people visit when sick to a service woven into ordinary life - which, for a platform trying to be a country's default front door to care, is the whole game.

telemedicinee-pharmacyhome lab testsinsurancesuper appindonesiahealthtech

In Their Words

Voices & video

"With over 20 million monthly active users, Halodoc has become part of how Indonesians access care - connecting patients with doctors, labs, pharmacies and insurance in one place."

"The name says the promise: halo plus doc - hello, doctor. The whole product is built around making that greeting effortless."

▶ Halodoc on YouTube ▶ App demo & how-to ▶ Jonathan Sudharta interviews

FAQ

Quick answers

What is Halodoc?

An Indonesian digital health app that lets users consult licensed doctors, order medicine for delivery, book home lab tests and hospital appointments, and buy health insurance - all in one place.

Who founded Halodoc and when?

It was founded in 2016 in Jakarta by Jonathan Sudharta (CEO) and Doddy Lukito.

How many people use Halodoc?

More than 20 million monthly active users across Indonesia, connected to 20,000+ doctors, 4,000+ pharmacies and 1,400+ hospitals.

How much funding has it raised?

Roughly US$258 million across six rounds, including a $100M Series D in 2023 led by Astra Digital, with investors like Temasek, Novo Holdings and Gojek.

How does Halodoc make money?

As a healthcare marketplace: margins on medicine and e-pharmacy, consultation and lab fees, hospital and insurance partnerships, and increasingly bundles and chronic-care subscriptions.

HalodocHello, Doctor.